Related Experiment Video
Updated: Jun 24, 2025

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Outcomes of childhood TB in countries with a universal BCG vaccination policy
J V Dias1, L Varandas2, L Gonçalves3
1Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Department of Paediatrics, Hospital Beatriz Ângelo, Loures.
Insights
Childhood tuberculosis (TB) outcomes remain concerning, with a 19.5% unfavorable outcome rate and a 6.1% case-fatality ratio. Targeted health policies are crucial to improve treatment results for pediatric TB patients.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Tuberculosis (TB) significantly impacts childhood morbidity and mortality.
- Underdiagnosis and limited data obscure the true burden of pediatric TB.
- Existing data underestimates the impact of childhood TB.
Purpose of the Study:
- To systematically review and characterize treatment outcomes in childhood tuberculosis.
- To provide updated epidemiological data on pediatric TB outcomes.
- To inform public health strategies for combating childhood TB.
Main Methods:
- Systematic review of studies published between 2000 and 2020.
- Inclusion of studies on children (0-14 years) in countries with universal BCG vaccination.
- Random effects meta-analysis to synthesize treatment outcome data.
Main Results:
- 35 articles were included from 1,806 references.
- Overall unfavorable outcome proportion was 19.5%; pooled case-fatality ratio was 6.1%.
- Case-fatality was higher in younger children (0-4 years: 6.6%) and TB/HIV co-infected children (15.1%).
Conclusions:
- Childhood TB treatment outcomes are still a significant global health concern.
- Intensified efforts and targeted health policies are needed for vulnerable pediatric populations.
- Addressing data gaps is essential to effectively manage and reduce the global TB burden in children.
Abstract:
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Vaccinations

